Copyright
©The Author(s) 2015.
World J Gastroenterol. Mar 7, 2015; 21(9): 2800-2806
Published online Mar 7, 2015. doi: 10.3748/wjg.v21.i9.2800
Published online Mar 7, 2015. doi: 10.3748/wjg.v21.i9.2800
EVL group(n = 20) | Combined group(n = 18) | P value | |
Sex | 0.208 | ||
M | 14 | 9 | |
F | 6 | 9 | |
Age (yr) | 53.55 ± 13.72 | 52.94 ± 14.96 | 0.897 |
Child-Pugh grade | 0.875 | ||
A | 9 | 8 | |
B | 11 | 10 | |
Etiology | 1.000 | ||
HBV-related | 10 | 10 | |
Alcohol | 2 | 1 | |
PBC | 2 | 2 | |
Cryptogenic | 4 | 4 | |
VP (mmHg) | 21.60 ± 3.25 | 22.04 ± 3.87 | 0.274 |
Varix grade | 0.612 | ||
F2 | 10 | 9 | |
F3 | 10 | 11 |
- Citation: Kong DR, Wang JG, Chen C, Yu FF, Wu Q, Xu JM. Effect of intravariceal sclerotherapy combined with esophageal mucosal sclerotherapy using small-volume sclerosant for cirrhotic patients with high variceal pressure. World J Gastroenterol 2015; 21(9): 2800-2806
- URL: https://www.wjgnet.com/1007-9327/full/v21/i9/2800.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i9.2800